Fase pré-analitica, desafio continuo no laboratorio clinico: uma revisão descritiva qualitativa

Para garantir toda sua qualidade no laboratório, o setor de Análises Clinicas e suas boas práticas, baseia -se na RDC 302/2005 da Anvisa, que orienta toda a formação, paramentação e boas práticas nas etapas do laboratório clinico. A fase pré-analítica corresponde a 70% dos erros que ocorrem em um laboratório clinico devido a toda sua complexidade e também por depender de profissionais de outras especialidades, a seguinte fase inicia -se em; pedido dos exames, preparo do paciente, colheita, identificação, transporte da amostra, armazenamento e preparação. Os erros culminam em perdas de amostras biológicas, conflito entre diferentes áreas do processo e prejuízo financeiro. O presente trabalho será uma revisão descritiva, qualitativa tendo o intuito de comparar diversas literaturas, revendo dados dos erros e suas melhorias com o passar do tempo

Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

Aims The European Society of Cardiology (ESC) EURObservational Research Programme (EORP) Non-ST-segment elevation myocardial infarction (NSTEMI) Registry aims to identify international patterns in NSTEMI management in clinical practice and outcomes against the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without ST-segment-elevation. Methods and results Consecutively hospitalised adult NSTEMI patients (n = 3620) were enrolled between 11 March 2019 and 6 March 2021, and individual patient data prospectively collected at 287 centres in 59 participating countries during a two-week enrolment period per centre. The registry collected data relating to baseline characteristics, major outcomes (inhospital death, acute heart failure, cardiogenic shock, bleeding, stroke/transient ischaemic attack, and 30-day mortality) and guideline-recommended NSTEMI care interventions: electrocardiogram pre- or in-hospital, prehospitalization receipt of aspirin, echocardiography, coronary angiography, referral to cardiac rehabilitation, smoking cessation advice, dietary advice, and prescription on discharge of aspirin, P2Y12 inhibition, angiotensin converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB), beta-blocker, and statin. Conclusion The EORP NSTEMI Registry is an international, prospective registry of care and outcomes of patients treated for NSTEMI, which will provide unique insights into the contemporary management of hospitalised NSTEMI patients, compliance with ESC 2015 NSTEMI Guidelines, and identify potential barriers to optimal management of this common clinical presentation associated with significant morbidity and mortality